Project I Test: Implementing HIV Testing in Opioid Treatment Programs
HIV/AIDS, Hepatitis C, Substance Use Disorders
About this trial
This is an interventional health services research trial for HIV/AIDS focused on measuring HIV, HIV Testing, Hepatitis C Virus Testing, Opioid Use Disorder Treatment, Substance Use Disorders Treatment, Hepatitis C Virus, Practice Coaching
Eligibility Criteria
Inclusion Criteria:
Eligible sites must:
- See at least 150 unduplicated patients/year/site
- Be capable and willing to prospectively collect data on the number of patients who a) are offered any HIV and/or HCV tests; b) completed these tests; c) are referred to care/evaluation (and type of referral) if positive; and d) are linked to care/evaluation within 30 days of diagnosis
- Be capable and willing to provide patient demographics, testing data within demographic categories of gender and race/ethnicity (in aggregate) and data on HIV/HCV test reimbursement processes and outcomes
- Have key staff willing to consent to participate in study surveys, qualitative interviews and intervention coaching throughout the study
Exclusion Criteria:
Sites will be excluded if:
- Over 50% of patients served in the prior 6 months were HIV or HCV tested
- They are terminated via PI decision/discretion
Sites / Locations
- Columbia University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Other
HIV Testing Practice Coaching Intervention Group
HIV and HCV Testing Practice Coaching Intervention Group
Information Control Group
The HIV Testing Practice Coaching (PC) Intervention is designed to improve the provision and sustained implementation of on-site HIV testing and linkage to care among OTP patients.
The HIV and HCV Testing Practice Coaching (PC) Intervention will leverage the HIV PC intervention and follow the same interventional steps described above, and, in addition, provide information and training to support joint HIV/HCV testing and linkage to care among OTP patients.
The administrators of OTPs assigned to the control condition will receive a website link to and hard copy of the NIDA/SAMHSA Blending Initiative product for HIV rapid testing.